Désiré Collen

Interventional / Structural Cardiology

Fujirebio (Belgium)

About

Désiré Collen works in Interventional / Structural Cardiology affiliated with Fujirebio (Belgium).

Désiré Collen is a Belgian physician and biochemist who serves as professor emeritus at KU Leuven. He is the founder and chairman of Fund+ NV, an investment fund focused on life sciences companies. He developed tissue plasminogen activator as a treatment for acute myocardial infarction and founded several biotech companies.

Research focus

Thrombolytic therapy for acute myocardial infarctionBlood coagulation and thrombosis mechanismsVenous thromboembolism diagnosis and managementVascular biologyTranslational research in cardiovascular drug development

Impact

535 pubs · 31,479 cites · h-index 79

Training

MD
KU Leuven
1968
MS in Chemistry
KU Leuven
1969
PhD in Chemistry
KU Leuven
1974

Affiliations

Work Experience

Professor Emeritus

KU Leuven · 2008 - Present

Chairman

Fund+ NV · 2015 - Present

Professor, Faculty of Medicine

KU Leuven · 1981 - 2008

Professor of Biochemistry and Medicine

University of Vermont College of Medicine · 1984 - 2005

Visiting Professor of Medicine

Harvard Medical School · 1987 - 1994